(30.7%), daily laborers (22.7%) and students (20%). All were first time donors, and 75% of the donations were replacement donations. The prevalence of HIV, Hepatitis B surface antigen (HBsAg) and Hepatitis C virus (HCV) infections were 4.5% (95CI: 3.0 6.6), 8.2% (95CI: 6.2 10.7) and 5.8% (95CI: 4.2 8.1) respectively. In univariate analysis, HCV and HIV infections were associated (OR: 5.36, 95CI: 2 14.3). Conclusion: The prevalence of TTIs among blood donors is very high and the majorities of blood donors are replacement or paid donors with one or more of the risk factors for TTIs implying that blood transfusion is unsafe. These findings call for the urgent implementation of the national strategy of safe blood transfusion in Ethiopia.
Poster Presentation Diagnosis & Laboratory Systems Development
PP-068 Survey of Anti-HBc and Anti-HBs prevalence in HBsAg-negative blood donors in Tehran Z. Alizadeh *, Z. Sharifi, S. Samiei. Iranian Blood Transfusion Organization-Research Center, Iran Background: Current serological screening for blood-borne hepatitis viruses has reduced the risk of post-transfusion hepatitis dramatically. Occult hepatitis B virus (HBV) infection might allow the release of viremic units into the blood supply network if blood is tested only for hepatitis B surface antigen (HBsAg). The screening for antibody to HBc (anti-HBc) has been shown as an alternative test for the detection of HBV infection. Objective: The aim of this study was to evaluate HBV infection markers prevalence in HBsAg-negative blood donors. Methods: In this descriptive cross-sectional study (in 2007), 2000 HBsAg-negative samples were collected from blood transfusion centers in Tehran. All HBsAg-negative samples were tested for anti-HBc using ELISA method. Then all HBsAg-negative and anti-HBc-positive samples were tested for anti-HBs by the same method. Data were analyzed statistically using chi-square test. Results: 199 out of the 2000 HBsAg-negative blood donors (9.95%) were anti-HBc-positive. Out of the 199 anti-HBcpositive samples tested for anti-HBs, 149 were anti-HBspositive (75%), and 100 had an antibody titer greater than 100 IU/mL (50.3%). Conclusion: In our study, the prevalence of anti-HBc in HBsAg-negative blood donors was high. While anti-HBc-positive blood may be a potential source of HBV transmission, routine application of anti-HBc screening is not feasible in our country, as it would seriously limit the blood supply. Therefore more sensitive techniques such as Minipool PCR testing after virus enrichment is essential for detecting HBV DNA in HBsAg-negative chronic HBV carriers.
PP-069 Development of RFLP-PCR assay to identify
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